4,037 research outputs found
Letter by Razzolini and Tarantini regarding article, "Restrictive Left Ventricular Filling Pattern Does Not Result From Increased Left Atrial Pressure Alone"
No full textComplex coronary disease in the post-SYNTAX era
No full textShould patients with high-risk coronary artery disease be treated with CABG or receive drug-eluting stents? The SYNTAX trial aimed to define the optimal revascularization strategy for patients with previously untreated three-vessel and/or left main coronary artery disease
Letter by Tarantini et al Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy"
No full textPercutaneous mitral valve commissurotomy
No full textTranscatheter therapies have progressively assumed a major role in the treatment of valve heart disease. The major drivers have been population ageing, the high prevalence of valve disease in the elderly, and the consequent need of less invasive treatments for this fragile patient population. While transcatheter aortic valve implantation (TAVI) has achieved a central role in the treatment of severe aortic stenosis across any surgical risk category, transcatheter treatment of mitral valve disease is still the object of intense debate and investigation. The reasons are that the mitral valve apparatus anatomy is more complex, involving valve leaflets, subvalvular apparatus and the left ventricle. Further, the most frequent mitral valve disease, i.e. mitral regurgitation, has different etiologies and is frequently a consequence rather than the cause of left ventricular dysfunction and heart failure. Hence, clinical efficacy of its correction is uncertain. Beyond the varying clinical scenarios, there are a miriad of devices under developement or at different stages of clinical investigations. This book describes the state of the art in the filed of percutaneous treatment of mitral valve disease. It provides a comprehensive review including anatomical basis, in-depth diagnostics, patophysiology, summary of available evidence for transcatheter treatments, state-of-the art of cardiac surgery,description of devices commercially available or under investigation, and clinical examples
Nothing is ever so good that it cannot stand a little revision: The advance of WATCHMAN iterations
No full textTranscatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone
No full textSingle‐access technique for Impella‐assisted PCI: How to take hold of Impella by the smooth handle
No full text
- …
